Reimagining vaccines for prostate cancer: Back to the future.

Reimagining vaccines for prostate cancer: Back to the future.
Clin Cancer Res. 2020 Jul 31;:
Authors: Shenderov E, Antonarakis ES
Abstract
Given the modest clinical benefits observed with immune checkpoint blockade in advanced prostate cancer, there is a renewed interest in exploring other forms of immunotherapy. Here the authors report the use of a novel plasmid DNA vaccine encoding the androgen receptor, called pTVG-AR, in men with metastatic hormone-sensitive prostate cancer.
PMID: 32737029 [PubMed - as supplied by publisher]

Source: Clinical Cancer Research - July 30, 2020 Category: Cancer & Oncology Authors: Shenderov E, Antonarakis ES Tags: Clin Cancer Res Source Type: research